Your session is about to expire
← Back to Search
AlloStim for Coronavirus Disease (ALLOPRIME Trial)
ALLOPRIME Trial Summary
This trial tests a new vaccine that could protect elderly adults from any type of viral infection, including COVID-19.
- Coronavirus Disease (COVID-19)
- Respiratory Syncytial Virus Pneumonia
- Acute Respiratory Distress Syndrome
- Viral Diseases
- Flu
- Pneumonia
ALLOPRIME Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ALLOPRIME Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Are recruitment efforts for this research still underway?
"Indeed, the clinicaltrials.gov website showcases that this trial is open and looking for patients right now. This specific study was posted on July 12th, 2021 and updated as recently as August 30th, 2022. The researchers need 40 individuals from 4 different areas to complete the trial."
Could you inform me as to how many research facilities are currently conducting this experiment?
"There are 4 sites where this trial is being conducted: Miami, Tampa, Zephyrhills and additional locations. To reduce the burden of travel, please select the location closest to you."
How many willing participants are there for this clinical trial?
"Yes, the trial is recruiting patients at this time. The clinical trial was posted on 7/12/2021 and most recently updated on 8/30/2022. They are looking for a total of 40 participants from 4 different locations."
Share this study with friends
Copy Link
Messenger